Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$465M |
| 2 |
Microsoft
MSFT
|
+$373M |
| 3 |
Amazon
AMZN
|
+$274M |
| 4 |
ExxonMobil
XOM
|
+$253M |
| 5 |
Meta Platforms (Facebook)
META
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$249M |
| 2 |
STJ
St Jude Medical
STJ
|
+$203M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$156M |
| 4 |
HAR
Harman International Industries
HAR
|
+$71.2M |
| 5 |
CSC
Computer Sciences
CSC
|
+$56.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.77% |
| 2 | Financials | 15.74% |
| 3 | Healthcare | 13.31% |
| 4 | Industrials | 10.5% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Enanta Pharmaceuticals
ENTA
$391M
| $3.71M | ﹤0.01% |
120,569
-12,015
| -9% | -$374K |
|
|
BRS
2252
DELISTED
Bristow Group, Inc.
BRS
| $3.71M | ﹤0.01% |
244,171
+4,983
| +2% | +$83.8K |
|
|
RVNC
2253
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.71M | ﹤0.01% |
178,435
+25,075
| +16% | +$515K |
|
2254
Inovio Pharmaceuticals
INO
$93M
| $3.71M | ﹤0.01% |
46,680
+5,170
| +12% | +$412K |
|
2255
TETRA Technologies
TTI
$1.25B
| $3.71M | ﹤0.01% |
910,912
+106,900
| +13% | +$481K |
|
|
UAM
2256
DELISTED
Universal American Corp
UAM
| $3.69M | ﹤0.01% |
370,300
+715
| +0.2% | +$7.12K |
|
2257
Caesars Entertainment
CZR
$6.04B
| $3.69M | ﹤0.01% |
194,984
+9,761
| +5% | +$165K |
|
|
WUBA
2258
DELISTED
58.com Inc
WUBA
| $3.69M | ﹤0.01% |
104,587
+10,357
| +11% | +$342K |
|
2259
Cerus
CERS
$572M
| $3.67M | ﹤0.01% |
823,882
+29,731
| +4% | +$126K |
|
|
TACO
2260
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $3.66M | ﹤0.01% |
276,260
+6,730
| +2% | +$90K |
|
|
FRED
2261
DELISTED
Fred's Inc
FRED
| $3.66M | ﹤0.01% |
279,569
+9,209
| +3% | +$145K |
|
2262
Bar Harbor Bankshares
BHB
$681M
| $3.66M | ﹤0.01% |
110,540
+51,657
| +88% | +$1.52M |
|
2263
Forestar Group
FOR
$1.51B
| $3.65M | ﹤0.01% |
267,465
+42,923
| +19% | +$562K |
|
2264
Weibo
WB
$1.88B
| $3.65M | ﹤0.01% |
70,163
+11,825
| +20% | +$588K |
|
|
RATE
2265
DELISTED
Bankrate Inc
RATE
| $3.65M | ﹤0.01% |
378,043
-82,457
| -18% | -$892K |
|
|
WLH
2266
DELISTED
WILLIAM LYON HOMES
WLH
| $3.64M | ﹤0.01% |
176,674
+5,649
| +3% | +$106K |
|
2267
Marcus & Millichap
MMI
$1.2B
| $3.64M | ﹤0.01% |
148,094
-2,316
| -2% | -$60K |
|
|
MITT
2268
TPG Mortgage Investment Trust
MITT
$214M
| $3.63M | ﹤0.01% |
66,950
+720
| +1% | +$38K |
|
2269
West Bancorporation
WTBA
$511M
| $3.63M | ﹤0.01% |
157,960
+3,965
| +3% | +$91.4K |
|
|
TARO
2270
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $3.62M | ﹤0.01% |
31,079
+2,295
| +8% | +$254K |
|
|
BSTC
2271
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $3.62M | ﹤0.01% |
66,059
+9,462
| +17% | +$501K |
|
2272
Teekay
TK
$1.06B
| $3.62M | ﹤0.01% |
395,181
+41,127
| +12% | +$398K |
|
2273
BlackLine
BL
$1.82B
| $3.6M | ﹤0.01% |
121,137
+6,386
| +6% | +$179K |
|
2274
CytomX Therapeutics
CTMX
$730M
| $3.6M | ﹤0.01% |
208,710
+16,991
| +9% | +$224K |
|
2275
Lineage Cell Therapeutics
LCTX
$268M
| $3.6M | ﹤0.01% |
1,192,581
+733,072
| +160% | +$2.08M |
|
Similar funds
Geode Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Geode Capital Management held 4,180 positions worth $244B, up 13% from $215B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Geode Capital Management deployed $16.9B of net new capital in Q1 2017, opening 139 new positions and adding to 3,365 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 786,074 shares worth $42.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Computer Sciences, an estimated $56.7M trimmed.
- Geode Capital Management's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 786,074 shares worth $42.8M.
- Geode Capital Management added most to Apple in Q1 2017, an estimated $465M increase.
- Geode Capital Management's biggest Q1 2017 reduction was Computer Sciences, cutting an estimated $56.7M.
- Geode Capital Management fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $249M.
- Geode Capital Management's ten largest holdings make up 16% of its $244B portfolio in Q1 2017.
- Geode Capital Management opened 139 new positions and closed 111 in Q1 2017.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $244B.
Based on Geode Capital Management's 13F filing for Q1 2017, filed 12 May 2017.